|
The field of pharmacogenomics is rapidly evolving as we learn more about the human genome and the natural variability that exists in our diverse culture. Pharmacogenomics, as the name implies, is the combination of two scientific disciplines: pharmacology (the study of drug action) and genomics (the comprehensive study of the entire genome). Therefore, pharmacogenomics involves understanding how an individual’s genetic inheritance (his/her genome) affects his/her body’s response to drugs.
The George Washington University is a pioneer in the field of pharmacogenomics offering the only Bachelor’s degree program in the country. Students are admitted into their Junior year to GW. During their first (Junior) year, students can apply to the Doctor of Pharmacy program at the renowned Bernard J. Dunn School of Pharmacy at Shenandoah University and, if accepted, would be admitted into the second year of the PharmD program after graduation from GW. The program is offered through a combination of in-class learning at the GW Foggy Bottom campus in Washington, DC and the Virginia campus in Ashburn, Virginia and online learning.
The program strives to educate a new generation of health science graduates who are acutely aware of the interface between human genetic variability and drug action. Our mission is to offer a world-class education to students and equip future pharmacists, scientists, physicians, policy makers and health care professionals with concrete knowledge and unparalleled experience in pharmacogenomics. Our graduates play integral roles in the resolution of the scientific, policy and ethical issues surrounding personalized medicine. The program will uniquely prepare individuals for a variety of positions in the biopharmaceutical industry and allied health professions as well as continued advanced education in health policy, medicine, pharmacological/genomic research and pharmacy.
|
Home
About Us
Academic Programs
Admissions
Student Services
Faculty Resources
